Merck KGaA (FRA:MRK) received a €100.00 ($117.65) price target from stock analysts at J P Morgan Chase & Co in a research report issued to clients and investors on Friday. The brokerage presently has a “neutral” rating on the healthcare company’s stock.

Several other research firms also recently issued reports on MRK. Nord/LB reaffirmed a “neutral” rating on shares of Merck KGaA in a report on Wednesday, June 28th. Oddo Bhf set a €125.00 ($147.06) price objective on shares of Merck KGaA and gave the stock a “buy” rating in a report on Friday, September 29th. Morgan Stanley set a €103.00 ($121.18) price objective on shares of Merck KGaA and gave the stock a “neutral” rating in a report on Monday, September 25th. Credit Suisse Group AG set a €106.00 ($124.71) price objective on shares of Merck KGaA and gave the stock a “neutral” rating in a report on Wednesday, July 26th. Finally, Goldman Sachs Group, Inc. (The) set a €105.00 ($123.53) price objective on shares of Merck KGaA and gave the stock a “neutral” rating in a report on Thursday, August 17th. Thirteen research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the stock. Merck KGaA currently has an average rating of “Hold” and an average target price of €109.43 ($128.75).

Merck KGaA (MRK) traded down 0.174% during midday trading on Friday, reaching €95.548. 1,583 shares of the company traded hands. The stock has a market capitalization of €41.54 billion and a price-to-earnings ratio of 24.908. Merck KGaA has a 12 month low of €89.00 and a 12 month high of €115.00. The firm has a 50 day moving average of €94.96 and a 200-day moving average of €101.84.

TRADEMARK VIOLATION WARNING: “Merck KGaA (MRK) Given a €100.00 Price Target at J P Morgan Chase & Co” was originally posted by American Banking News and is owned by of American Banking News. If you are reading this report on another site, it was illegally copied and reposted in violation of United States & international copyright laws. The original version of this report can be viewed at https://www.americanbankingnews.com/2017/10/06/merck-kgaa-mrk-given-a-100-00-price-target-at-j-p-morgan-chase-co-2.html.

About Merck KGaA

.

Analyst Recommendations for Merck KGaA (FRA:MRK)

Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.